Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1965 1
1975 1
1977 1
1978 1
1991 1
1999 1
2001 1
2002 1
2005 1
2006 2
2007 7
2008 3
2009 4
2010 6
2011 10
2012 7
2013 8
2014 11
2015 11
2016 6
2017 4
2018 2
2019 9
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
Highly conserved influenza T cell epitopes induce broadly protective immunity.
Eickhoff CS, Terry FE, Peng L, Meza KA, Sakala IG, Van Aartsen D, Moise L, Martin WD, Schriewer J, Buller RM, De Groot AS, Hoft DF. Eickhoff CS, et al. Among authors: Moise L. Vaccine. 2019 Aug 23;37(36):5371-5381. doi: 10.1016/j.vaccine.2019.07.033. Epub 2019 Jul 19. Vaccine. 2019. PMID: 31331771
Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.
Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, De Groot AS, Ato M, Takahashi Y. Wada Y, et al. Among authors: Moise L. Sci Rep. 2019 Oct 8;9(1):14730. doi: 10.1038/s41598-019-50828-3. Sci Rep. 2019. PMID: 31594990 Free PMC article.
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.
Hoffmann PR, Hoffmann FW, Premeaux TA, Fujita T, Soprana E, Panigada M, Chew GM, Richard G, Hindocha P, Menor M, Khadka VS, Deng Y, Moise L, Ndhlovu LC, Siccardi A, Weinberg AD, De Groot AS, Bertino P. Hoffmann PR, et al. Among authors: Moise L. Front Oncol. 2019 Aug 2;9:720. doi: 10.3389/fonc.2019.00720. eCollection 2019. Front Oncol. 2019. PMID: 31428586 Free PMC article.
Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.
Scholzen A, Richard G, Moise L, Baeten LA, Reeves PM, Martin WD, Brauns TA, Boyle CM, Raju Paul S, Bucala R, Bowen RA, Garritsen A, De Groot AS, Sluder AE, Poznansky MC. Scholzen A, et al. Among authors: Moise L. Front Immunol. 2019 Feb 15;10:207. doi: 10.3389/fimmu.2019.00207. eCollection 2019. Front Immunol. 2019. PMID: 30828331 Free PMC article.
A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
Hewitt JS, Karuppannan AK, Tan S, Gauger P, Halbur PG, Gerber PF, De Groot AS, Moise L, Opriessnig T. Hewitt JS, et al. Among authors: Moise L. Vaccine. 2019 Jul 18;37(31):4302-4309. doi: 10.1016/j.vaccine.2019.06.044. Epub 2019 Jun 24. Vaccine. 2019. PMID: 31248687
Agility in adversity: Vaccines on Demand.
De Groot AS, Moise L, Olive D, Einck L, Martin W. De Groot AS, et al. Among authors: Moise L. Expert Rev Vaccines. 2016 Sep;15(9):1087-91. doi: 10.1080/14760584.2016.1205951. Epub 2016 Jul 18. Expert Rev Vaccines. 2016. PMID: 27389971 Review.
microRNAs Expression as Novel Genetic Biomarker for Early Prediction and Continuous Monitoring in Pulmonary Cancer.
Nitu R, Rogobete AF, Gundogdu F, Tanasescu S, Boruga O, Sas A, Popovici SE, Hutanu D, Pilut C, Sarau CA, Candea AC, Stan AT, Moise LM. Nitu R, et al. Among authors: Moise LM. Biochem Genet. 2017 Aug;55(4):281-290. doi: 10.1007/s10528-016-9789-y. Epub 2017 Jan 9. Biochem Genet. 2017. PMID: 28070693 Review.
VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.
Leblanc P, Moise L, Luza C, Chantaralawan K, Lezeau L, Yuan J, Field M, Richer D, Boyle C, Martin WD, Fishman JB, Berg EA, Baker D, Zeigler B, Mais DE, Taylor W, Coleman R, Warren HS, Gelfand JA, De Groot AS, Brauns T, Poznansky MC. Leblanc P, et al. Among authors: Moise L. Hum Vaccin Immunother. 2014;10(10):3022-38. doi: 10.4161/hv.34413. Hum Vaccin Immunother. 2014. PMID: 25483693 Free PMC article. Review.
94 results
Jump to page
Feedback